STAT Plus: Regeneron drug reduces bone growth for patients with ultra-rare skeletal disease
Patients with the ultra-rare disease FOP grow bone where it doesn’t belong, creating a life-threatening…
Author: STAT
Opinion: Some people in persistent vegetative states have working minds. Does keeping them in limbo amount to torture?
Imagine for a minute — or even for a few seconds — that your working…
Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show
PIKEVILLE, Ky. — A year and a half after the opioid painkiller OxyContin went on…
The ghosts of JPMs past: How 20 years of deals, scandal, and science have shaped health care
Biotech is celebrating a platinum anniversary next week: 20 years since J.P. Morgan took over…
Opinion: Did a high-profile program really slash hospital spending? Or was it a cautionary tale of ‘regression to the mean’?
In the late 19th century, English polymath Sir Francis Galton noted that tall parents often…
WHO says mysterious illness in China likely being caused by new virus
The World Health Organization confirmed on Wednesday that Chinese authorities believe a new coronavirus —…
STAT Plus: Pharmalittle: Execs vow to place patients ahead of profits; conservatives like Republican drug pricing bill
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
U.S. cancer death rate drops by largest annual margin ever, report says
NEW YORK — Researchers on Wednesday reported the largest-ever one-year decline in the U.S. cancer…
Opinion: Medicare policy on antirejection drugs imperils kidney transplants
For people with failing kidneys — and there are thousands of them in the United…
Opinion: A new biotechnology and pharmaceutical industry commitment to patients and the public
We,the undersigned leaders in the biotechnology and pharmaceutical industries, academia, and life science investors, recognize…
STAT Plus: A Q&A with FDA’s Amy Abernethy on how the agency is grappling with digital health regulation
LAS VEGAS — The Food and Drug Administration announced this week it will hold a…
At 2020 deadline, progress in Patrick Soon-Shiong’s ‘cancer moonshot’ is hard to find
In 2016, the biotech billionaire Dr. Patrick Soon-Shiong set himself a deadline: By 2020, he…
STAT Plus: Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders
Pear Therapeutics has struck a deal to license voice biomarkers to try to improve treatment…
Conservative group with pharma ties makes clear there are drug pricing reforms they can support
WASHINGTON — The conservative American Action Network launched a $4 million advertising campaign Tuesday to…
STAT Plus: Pharmalittle: Few vets were treated with antidepressant Trump touted; Pelosi lashes out at price hikes
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: 3 legal challenges could derail out-of-network surprise medical bills
Surprise medical bills have become the bane of many Americans who are seen in emergency…
Trump touted a new antidepressant as a solution for veterans. Only 15 have been treated
In August, President Trump proudly proclaimed that he had directed the Department of Veterans Affairs…
STAT Plus: Biotech 2020 preview: Takeover targets, notable drug launches, and genome editing readouts
Hello, Biotech 2020. True, we’re already six days into the new year, but the first…
Cause of Wuhan’s mysterious pneumonia cases still unknown, Chinese officials say
The cause of mysterious pneumonia cases in the Chinese city of Wuhan remains unknown, health…
Experts search for answers in limited information about mystery pneumonia outbreak in China
The mysterious and growing cluster of unexplained pneumonia cases in the Chinese city of Wuhan…
STAT Plus: Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals
A federal judge dealt the pharmaceutical industry a setback by declining to block a new…
.jpg)
STAT Plus: Pharmalittle: Lab urges FDA to recall all forms of Zantac; end-of-year FDA approval rush has unintended consequence
And so, another working week will soon draw to a close. A little quicker than…
Opinion: Health care providers are unrecognized victims of mass killings. We’re doing little to support them
The night a gunman opened fire on a crowd of 20,000 at a Las Vegas…
A spate of new class-action lawsuits threaten the CBD industry. Will they force Washington to act?
WASHINGTON — Since the Food and Drug Administration can’t figure out whether supplements that contain…
STAT Plus: The biotech scorecard for the first quarter: 14 stock-moving events to watch
Here is STAT’s Biotech Scorecard, our regular ledger of stock-moving biotech events, for the first…
Trump plan to curb teen vaping exempts some flavors
WASHINGTON — U.S. health officials will ban most flavored e-cigarettes popular with underage teenagers, but…
Opinion: CRISPR babies scientist He Jiankui should not be villainized — or headed to prison
When I saw the news that He Jiankui and colleagues had been sentenced to three…
STAT Plus: An uncommon form of dementia hits at a younger age. Drug makers are searching for a treatment
Growing up in the 1970s, Jary Larsen heard his mother say their extended family had…
STAT Plus: It’s ‘business as usual’ as many drug makers boost prices for the new year
A new year often means higher prices for prescription medicines and 2020 is no exception….
STAT Plus: Pharmalittle: FDA failed to police opioid prescribing program; Novo launches plan to mitigate insulin cost
Good morning, everyone, and welcome to a new year. We hope the extended respite —…
This mental health advocate wants to make addiction and behavioral health a 2020 election issue
WASHINGTON — A top mental health and addiction treatment advocate here wants behavioral health on…
3 drug pricing policy experiments to watch in 2020
WASHINGTON — Politicians spent the better part of 2019 bickering over the best way to…
Google AI tool can pinpoint breast cancer better than clinicians, new study suggests
Researchers at Google, working alongside experts at Northwestern University and three British medical institutions, have…
Delivering the TB vaccine by IV better protects monkeys, new study finds
A new study suggests that a simple tweak could make a century-old vaccine for tuberculosis…
Opinion: He Jiankui is going to jail. Would the U.S. criminally prosecute a rogue gene-editing researcher?
On Monday, 13 months after He Jiankui announced that he had created the world’s first…
Opinion: Antibiotic resistance nearly killed me. That’s why I’m raising awareness of it
There are many reasons why people write about the looming threat of antibiotic resistance. Academics…
STAT Plus: STAT’s guide to the most important, beneficial drugs approved in the past decade
The new year will end in a zero, making this a perfect opportunity to look…
2019 in limericks: The highs and lows from the life sciences
It’s the eve of a new life sciences year, and we’ve got our party hats…
He Jiankui, who created world’s first CRISPR’d babies, sentenced to three years in prison
A Chinese court on Monday sentenced He Jiankui, the scientist who made the world’s first…
Opinion: Precision medicine has a blind spot: children with cancer
Cancer, once a terrifying black box, is slowly being opened up. Thanks to advances in…
Opinion: We ventured into the Medicare Part D drug plan forest — and got lost
My wife and I recently became eligible for Medicare’s prescription drug coverage, known as Medicare…
STAT’s most memorable photos of 2019
In the last year, STAT’s contributing photographers have been inside operating rooms, kayaked into polluted…
.jpg)
What will 2020 bring for medicine and science? We asked 16 leaders for predictions
Last year, when we asked science and health care soothsayers to peak ahead to 2019,…
A final fundraiser for Pete Frates, champion of the ice bucket challenge
GLOUCESTER, Mass. — Hundreds of people plunged into the chilly ocean at a Massachusetts beach…
Opinion: 5 most widely read First Opinions of 2019
It’s been a banner year for First Opinion. We published nearly 500 essays written by…
3 congressional races to watch in 2020
WASHINGTON — Drug prices are on the ballot once again in 2020. It’s already evident…
STAT Plus: Crash and burn: The four biggest biopharma failures of 2019
In biotech, companies fail for a lot of reasons. The science might not quite work,…
Opinion: Improving the next generation of drugs through patient-centric design for clinical trials
When a process works, it’s natural to try to repeat it rather than recreate or…
3 challenges to watch in global health in 2020
New Year’s Day may usher in a new decade, but our crystal ball suggests some…
3 trends in biotech to watch in 2020
For biotech, 2019 ended like the penultimate episode of a prestige TV show. We got…